Market Analysis — BALTIMORE WASHINGTON MEDICAL CENTER
MD market | 3 hospitals | HHI: 5,070 (Concentrated)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
3
Hospitals in Market
709
Total Beds
$1.1B
Market Revenue
Concentrated
HHI: 5,070
Narrow
Moat Rating (6/10)
#2
Market Share Rank
Competitive Moat (Mauboussin Framework)
Based on "Measuring the Moat" adapted for healthcare. Score 0-10: wide (8+), narrow (5-7), none (<5).
Scale Advantagemoderate
Switching Costshigh
Market Share41.4%
Top 3 Concentration100.0%
Network Density0.42
Margin vs Market+0.0%
Bed Util vs Market+11.6%
What This Means
This hospital has a narrow moat — narrow moat — some competitive advantages, but vulnerable to new entrants. The MD market is highly concentrated — few dominant players, potential antitrust concerns (HHI: 5,070).
Implications: Operational improvements are the primary value driver — see the EBITDA bridge. Compare against peers via comparables or see the full MD market.
Top Competitors
| Hospital | Beds | Revenue | Rev Share | Bed Share |
|---|---|---|---|---|
| ANNE ARUNDEL MEDICAL CENTER INC. | 379 | $617M | 58.0% | 53.5% |
| J KENT MCNEW FAMILY MEDICAL CENTER | 16 | $7M | 0.7% | 2.3% |
Regional Payer Mix
■ Medicare 30%■ Medicaid 5%■ Commercial 64%